...
首页> 外文期刊>Cancer gene therapy >14-3-3 eta depletion sensitizes glioblastoma cells to irradiation due to enhanced mitotic cell death
【24h】

14-3-3 eta depletion sensitizes glioblastoma cells to irradiation due to enhanced mitotic cell death

机译:14-3-3 eta耗竭使胶质母细胞瘤细胞对放射的敏感性增加,这是由于有丝分裂细胞死亡的增加

获取原文
           

摘要

14-3-3 proteins have important roles in several cellular processes such as cell cycle progression, the DNA-damage checkpoint and apoptosis. We have shown previously that depleting 14-3-3η, a 14-3-3 isoform, enhances mitotic cell death, and that combining it with microtubule agents is more effective for anticancer therapeutics. In this study, we investigated whether depleting 14-3-3η can be combined with radiotherapy to enhance its therapeutic efficacy. We found that depleting 14-3-3η resulted in a synergistic radiosensitizing effect when combined with radiotherapy in several glioblastoma cell lines, where its specific expression and correlation of its expression level with malignancy have been reported. The radiosensitizing effect was associated with enhanced mitotic cell death by 14-3-3η depletion but not with mitotic catastrophe, which is one of the major cell death mechanisms observed in response to irradiation of most solid tumors. These results suggest that 14-3-3η may be a therapeutic target to overcome radioresistance in glioblastoma.
机译:14-3-3蛋白在几种细胞过程中具有重要作用,例如细胞周期进程,DNA损伤检查点和凋亡。先前我们已经表明,消耗14-3-3η(一种14-3-3的同工型)会增加有丝分裂细胞的死亡,并且将其与微管剂结合使用对于抗癌治疗更有效。在这项研究中,我们调查了消耗性14-3-3η是否可以与放疗结合以增强其治疗效果。我们发现,在几种胶质母细胞瘤细胞系中,与放疗联合使用时,耗竭的14-3-3η会产生协同的放射增敏作用,据报道,该细胞系的特异性表达及其表达水平与恶性肿瘤相关。放射增敏作用与通过14-3-3n耗竭而增加的有丝分裂细胞死亡有关,但与有丝分裂灾难无关,这是对大多数实体瘤的辐射反应中观察到的主要细胞死亡机制之一。这些结果表明14-3-3η可能是克服胶质母细胞瘤放射线抵抗的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号